Moreover, Gene co-expression network analysis enlightens us that abnormal adaptive immune activation and specific CD16-related Immune paralysis blocking by targeting FCGR3A and FGL2 might be a new idea for treating glioma. Here, FGL2 is linked to central nervous system cancer.